Table 2.
Cycles | Cycles with ET | % | Age | PR/ET in % | path. PR/ET% | TEP n | TEP/ET in % | TEP/PR/ET% | |
---|---|---|---|---|---|---|---|---|---|
Group I–VI (SG) | 481 | 414 | 86.1 | 33.8 ± 4.8 | 32.1 | 9.2 | 10+1bilateral (12) | 2.9 | 8.95 |
Group I | 72 | 62 | 86.1 | 35.4 ± 3.9 | 33.9 | 6.5 | 2 | 3.2 | 9.5 |
Group II | 56 | 49 | 87.5 | 34.1 ± 4.6 | 38.8 | 12.3 | 0 | 0 | 0 |
Group III | 53 | 47 | 88.7 | 33.5 ± 4.7 | 27.7 | 4.3 | 1 | 2.1 | 7.7 |
Group IV | 177 | 151 | 85.3 | 33.9 ± 4.5 | 30.5 | 10.6 | 3+1heterotopic P(4) | 2.7 | 8.7 |
Group V | 75 | 65 | 86.7 | 32.5 ± 5.1 | 38.5 | 15.4 | 3+1bilateral TEP (5) | 7.7 | 24 |
Group VI | 48 | 40 | 83.3 | 33.2 ± 5.5 | 22.5 | 2.5 | 0 | 0 | 0 |
Control Group | 429 | 414 | 100 | 33.8 ± 4.9 | 32.5 | 9.5 | 1 | 0.24 | 0.75 |